Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolioOmeros is…
PRECISE study to generate pivotal clinical data for the Symani® Surgical System in free tissue transfer and lymphatic surgical repairJACKSONVILLE,…
BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company…
Atlas H&E-TME delivers robust analyses at single-cell resolution in hours BERLIN and NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Following…
The annual list honors groundbreaking advancements redefining the way we work and live CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ --…
Collaboration expands access to scalable, cost-efficient single-cell RNA sequencing for translational and clinical research MORRISVILLE, N.C. and SAN DIEGO, Oct.…
BELLEVUE, Wash., Oct. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced that it has executed a definitive agreement…
CHICAGO, Oct. 14, 2025 /PRNewswire/ -- Sibel Health, an award-winning digital health company, today announced the close of a Series…
BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ:ENTO) has reinvented itself in a way…
Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research programThis United States Controlled Substances…